Understand the offer
What changes when a medicine is made to order?
A familiar drug name is only part of the answer. Ask what exact product would reach you and who makes it.
Compounding means preparing a medicine to order.
Compounding means a pharmacy or doctor makes a medicine suited to a particular patient’s needs.
FDA stands for Food and Drug Administration. The agency reviews medicines.
Made-to-order medicines lacked FDA approval as of September 26, 2026.
Before these medicines are sold, FDA does not check how safe they are, their quality or how well they work.
An approved medicine may leave a patient need unmet; a made-to-order medicine may fill that gap.
- What need makes an approved product unsuitable for me?
- Which pharmacy prepares this particular medicine?
- What information will come with it?
There are limits on making copies.
Rules checked September 26, 2026 barred a regular pharmacy from repeatedly making close copies of ready-made medicines or making them in large amounts. These are medicines that are much the same as a product already sold.
An exception applies when the person ordering the medicine decides a change makes a significant difference for that specific patient.
A dye allergy is one example: a patient may need the medicine prepared without that dye.
Ask what change is proposed and why it matters for your own health.
A lower price alone does not establish that difference.
- FDA’s national shortage list did not include semaglutide injections or tirzepatide injections when checked September 26, 2026.
- An empty shelf at one pharmacy does not count as that national listing.
- FDA’s warning about unapproved weight medicines names retatrutide and cagrilintide. As of September 26, 2026, neither was an ingredient in an FDA-approved medicine. Neither had been found safe and shown to work for any health problem. Federal law did not allow either drug to be made to order.
A research label is not a path to treatment.
As recorded September 26, 2026, FDA’s advice was to avoid weight-drug products with research labels that were sold for human use.
The agency said their quality was unknown and they could be harmful.
- Ask which kind of product is on offer and why it fits the care proposed for you.
- Ask for the medicine name and pharmacy name in writing.